🇺🇸 FDA
Pipeline program

Losmapimod

A092519

Phase 2 small_molecule completed

Quick answer

Losmapimod for Chronic Obstructive Pulmonary Disease is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Chronic Obstructive Pulmonary Disease
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials